http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2543103-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b85127c42554a6ac6e5ecfb951e57578
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-0204
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-0212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-32
filingDate 2011-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7f9812d7bcf18f23d22a9c3836c7c0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_827df83cdde42a535d060504904c8598
publicationDate 2015-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2543103-T3
titleOfInvention Biocompatible collagen matrices stabilized against degradation
abstract Process for the production of crosslinked collagen matrices comprising the steps: a) prepare an aqueous collagen suspension, b) adjust the pH value of the collagen suspension from stage a) to pH <4, c) if necessary add other structure formers, active ingredients and / or auxiliary substances, d) add an epoxifunctional crosslinking agent, the order of stages c) and d) being variable, e) freeze the collagen mixture that can be obtained from stage d), f) lyophilize the frozen mixture from step e) at a lyophilization temperature <100 ° C g) optionally adjust the lyophilized crosslinked collagen material which can thus be obtained at a moisture content of up to 25% by weight, with respect to to the final product and h) if necessary transfer the materials that can be obtained from step g) to the desired mold, sterilize and / or make.
priorityDate 2010-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424968158
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4363005
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33727
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565880
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID173839
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17046

Total number of triples: 39.